INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 80 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $25,000 | +127.3% | 20,611 | +20.4% | 0.00% | – |
Q2 2022 | $11,000 | -79.6% | 17,123 | +1.5% | 0.00% | – |
Q1 2021 | $54,000 | +38.5% | 16,873 | -12.7% | 0.00% | – |
Q4 2017 | $39,000 | -99.4% | 19,325 | -95.3% | 0.00% | -100.0% |
Q4 2014 | $6,970,000 | +98.6% | 412,656 | +49.8% | 0.06% | +60.0% |
Q2 2014 | $3,509,000 | – | 275,421 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 7,866,108 | $25,408,000 | 4.32% |
Nine Chapters Capital Management LLC | 91,500 | $296,000 | 0.40% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,969,225 | $6,361,000 | 0.24% |
Orbimed Advisors | 3,250,300 | $10,498,000 | 0.12% |
PINNACLE ASSOCIATES LTD | 1,306,679 | $4,221,000 | 0.08% |
PLATINUM INVESTMENT MANAGEMENT LTD | 810,232 | $2,617,000 | 0.07% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 270,417 | $873,000 | 0.06% |
Rock Springs Capital Management LP | 270,000 | $872,000 | 0.05% |
ALGERT GLOBAL LLC | 39,876 | $129,000 | 0.04% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 391,671 | $1,265,000 | 0.03% |